Quick Answer
BioLineRx Ltd. reported Total Assets of $40.91 million for fiscal year 2025.
BioLineRx Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $40.91M | +5.1% |
| 2024 | $38.91M | -39.1% |
| 2023 | $63.92M | -16.3% |
| 2022 | $76.38M | -6.2% |
| 2021 | $81.39M | +72.1% |
| 2020 | $47.29M | -11.7% |
| 2019 | $53.57M | -4.7% |
| 2018 | $56.23M | -7.8% |
| 2017 | $60.97M | +56.6% |
| 2016 | $38.94M | — |
- BioLineRx Ltd. showed an increase of +5.1% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, BioLineRx Ltd.’s total assets has grown by 5.0% (from $38.94 million to $40.91 million).
- The most recent figure is from BioLineRx Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: